Hiroshi Kagamu

9PUBLICATIONS
55CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion.

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLC.

|Mar 28, 2026
The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment.

Shota Takei, Satoshi Yamasaki, Ou Yamaguchi

|Mar 27, 2026
Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Yu Miura, Hisao Imai, Satoshi Endo

|Jun 27, 2025
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study.

Yuhei Kurata, Atsuto Mouri, Hisao Imai

|May 08, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).

Hiroyuki Kodama, Yukiya Narita, Michio Nakamura

Pageof 2

Frequent Collaborators

6 joint publications

Hisao Imai

4 joint publications

Kyoichi Kaira

3 joint publications

Satoshi Yamasaki

3 joint publications

Kunihiko Kobayashi